Johnson & Johnson (JNJ)
(Delayed Data from NYSE)
$146.67 USD
+1.39 (0.96%)
Updated May 31, 2024 03:59 PM ET
After-Market: $146.60 -0.07 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$146.67 USD
+1.39 (0.96%)
Updated May 31, 2024 03:59 PM ET
After-Market: $146.60 -0.07 (-0.05%) 7:58 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Zacks News
Is the Earnings Picture Improving?
by Sheraz Mian
There are some tell-tale signs of improvement in the aggregate earnings picture.
Is the Earnings Picture Improving?
by Sheraz Mian
There are some tell-tale signs of improvement in the aggregate earnings picture.
Stock Market News for July 20, 2016
by Zacks Equity Research
The Dow ended in the green for the eighth consecutive session on Tuesday following Johnson & Johnson's commendable quarterly performance
MedTech Industry Stock Outlook - July 2016
by Zacks Equity Research
Two full quarters of 2016 are behind us and, while we await second quarter results over the coming weeks, we hardly expect a change in trend in the bullish MedTech sector.
Stock Market News for June 03, 2016
by Zacks Equity Research
Benchmarks finished in the green on Thursday following encouraging U.S. private sector jobs data and gains in healthcare stocks
Hedge Funds Are Buying These Stocks, Should You?
by Jeremy Mullin
Following the smart money can lead to big gains.
Bear of the Day: AbbVie (ABBV)
by Kevin Cook
Estimates were already sliding before the Feds took up the patent fight by "hopeful rival" Coherus
3 Incredible Stocks Charts You Must See
by Tracey Ryniec
Beating the estimate 5 years in a row and shares at all time highs? No problem.
5 Skyrocketing Momentum Stocks
by David Bartosiak
Five red hot momentum stocks breaking out to new highs
Winning Stock Picks from the Top 5 Industries with the Biggest Job Growth
by Kevin Matras
Kevin Matras goes over how to find winning stock-picking ideas in the government's 'boring' economic reports. Highlighted stocks include DG, UFPI, JNJ, TXRH and DEI.
MedTech Industry Stock Outlook - March 2015
by Zacks Equity Research
Emerging market expansion, positive demographic trends and new product innovation have been the vital forces behind the continued uptrend of the sector's performance.
MedTech Industry Stock Outlook - March 2015
by Zacks Equity Research
Emerging market expansion, positive demographic trends and new product innovation have been the vital forces behind the continued uptrend of the sector's performance.
MedTech Industry Stock Outlook - Dec. 2015
by Zacks Equity Research
While the global economy has been on a rollercoaster ride over the past quarter, the MedTech sector has not only held its own, but maintained a stable uptrend.
MedTech Industry Stock Outlook - Dec. 2015
by Zacks Equity Research
While the global economy has been on a rollercoaster ride over the past quarter, the MedTech sector has not only held its own, but maintained a stable uptrend.
Q3 Earnings Season Preview
by Sheraz Mian
All the big banks are on this week's reporting docket
Crash-Proof Stocks To Buy Now
by Brian Bolan
Crashes happen, but not all stocks are treated the same during the crash.
MedTech Industry Stock Outlook - July/Aug 2015
by Zacks Equity Research
Recently released government data showed that about 16.4 million uninsured people have gained health insurance coverage since the enactment of the Affordable Care Act five years back.
MedTech Industry Stock Outlook - July/Aug 2015
by Zacks Equity Research
Recently released government data showed that about 16.4 million uninsured people have gained health insurance coverage since the enactment of the Affordable Care Act five years back.
Banks in Focus as Q2 Earnings Season Ramps Up
by Sheraz Mian
Banks had an overall decent time in Q2.
MedTech Industry Stock Outlook - March 2015
by Zacks Equity Research
The Republican- led House proposed budget -- which calls for a repeal of Obamacare in its entirety -- came as a bit of good news for the MedTech majors.
MedTech Industry Stock Outlook - March 2015
by Zacks Equity Research
The Republican-led House proposed budget -- which calls for a repeal of Obamacare in its entirety -- came as a bit of good news for the MedTech majors.
MedTech Industry Stock Outlook - March 2015
by Zacks Equity Research
The Republican-led House proposed budget -- which calls for a repeal of Obamacare in its entirety -- came as a bit of good news for the MedTech majors.
Vertex Pharmaceuticals Posts Narrower-than-Expected Loss
by Zacks Equity Research
Vertex Pharmaceuticals's (VRTX) third-quarter 2014 loss came in at 56 cents per share wider than the year-ago loss of 46 cents.
A Good Start to Q2 Earnings Season
by Sheraz Mian
The 2014 Q2 earnings season has gotten off to a relatively positive start.